New Ranking Method Improves Antiseizure Drug Predictions for Patients

Source: Epilepsia

Summary

Researchers studied how well different animal models can predict the effectiveness of antiseizure medications (ASMs) for people with focal drug-resistant epilepsy (DRE). They looked at 23 ASMs approved by the U.S. Food and Drug Administration (FDA) and compared their performance in six different rodent models of seizures. The goal was to see if these models could help identify which medications might work best in clinical trials for patients who do not respond to standard treatments.

The key finding was that using a combination of results from multiple animal models provided better predictions of how effective the medications would be in humans. Specifically, when researchers ranked the ASMs based on their performance in two to four different seizure models, they found a strong connection to the success rates of those medications in clinical trials. This means that looking at several models together can give a clearer picture of which drugs might help patients with focal DRE.

This research is important because it could help guide future studies on new epilepsy medications, making it easier to find promising treatments for patients who struggle with seizures. However, it is worth noting that while the study shows a better way to predict effectiveness, it still relies on animal models, which may not perfectly reflect how medications work in humans. More research is needed to confirm these findings and to explore how they can be applied in real-world settings.

Original source